This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mallory, J. C.
Right arrow Articles by Craven, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mallory, J. C.
Right arrow Articles by Craven, R. J.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, March 2005, p. 1669-1679, Vol. 25, No. 5
0270-7306/05/$08.00+0     doi:10.1128/MCB.25.5.1669-1679.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Dap1p, a Heme-Binding Protein That Regulates the Cytochrome P450 Protein Erg11p/Cyp51p in Saccharomyces cerevisiae

Julia C. Mallory,1 Gerard Crudden,1 Ben L. Johnson,1 Caiqing Mo,2 Charles A. Pierson,2 Martin Bard,2 and Rolf J. Craven1*

Department of Molecular and Biomedical Pharmacology, Markey Cancer Center, University of Kentucky, Lexington, Kentucky,1 Department of Biology, Indiana University—Purdue University at Indianapolis, Indianapolis, Indiana2

Received 17 August 2004/ Returned for modification 4 October 2004/ Accepted 29 November 2004

Alkylating agents chemically modify DNA and cause mutations that lead to cancer. In the budding yeast Saccharomyces cerevisiae, resistance to the alkylating agent methyl methanesulfonate (MMS) is mediated in part by Dap1p (damage resistance protein 1). Dap1p is related to cytochrome b5, which activates cytochrome P450 proteins, elevating the metabolism of lipids and xenobiotic compounds. We have found that Dap1p, like cytochrome b5, binds to heme and that Dap1p targets the cytochrome P450 protein Erg11p/Cyp51p. Genetic analysis indicates that Erg11p acts downstream of Dap1p. Furthermore, Dap1p regulates the stability of Erg11p, and Erg11p is stabilized in dap1{Delta} cells by the addition of heme. Thus, Dap1p utilizes heme to stabilize Erg11p, which in turn regulates ergosterol synthesis and MMS resistance. Dap1p homologues have been identified in numerous eukaryotes, including mammals, suggesting that the Dap1p-cytochrome P450 protein pathway is broadly conserved in eukaryotic species.

* Corresponding author. Mailing address: Department of Molecular and Biomedical Pharmacology, University of Kentucky, MS-305 UKMC, Lexington, KY 40536. Phone: (859) 323-3832. Fax: (859) 257-9608. E-mail: rolf.craven{at}uky.edu.

Molecular and Cellular Biology, March 2005, p. 1669-1679, Vol. 25, No. 5
0022-538X/05/$08.00+0     doi:10.1128/MCB.25.5.1669-1679.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Craven, R. J., Mallory, J. C., Hand, R. A. (2007). Regulation of Iron Homeostasis Mediated by the Heme-binding Protein Dap1 (Damage Resistance Protein 1) via the P450 Protein Erg11/Cyp51. J. Biol. Chem. 282: 36543-36551 [Abstract] [Full Text]  
  • Crudden, G., Chitti, R. E., Craven, R. J. (2006). Hpr6 (Heme-1 Domain Protein) Regulates the Susceptibility of Cancer Cells to Chemotherapeutic Drugs. J. Pharmacol. Exp. Ther. 316: 448-455 [Abstract] [Full Text]  
  • Mallory, J. C., Crudden, G., Oliva, A., Saunders, C., Stromberg, A., Craven, R. J. (2005). A Novel Group of Genes Regulates Susceptibility to Antineoplastic Drugs in Highly Tumorigenic Breast Cancer Cells. Mol. Pharmacol. 68: 1747-1756 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»